Brainsway Ltd. - ADR earnings per share and revenue
On Nov 11, 2025, BWAY reported earnings of 0.13 USD per share (EPS) for Q3 25, beating the estimate of 0.09 USD, resulting in a 35.63% surprise. Revenue reached 45.34 million, compared to an expected 45.83 million, with a -1.07% difference. The market reacted with a -5.83% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of 0.13 USD, with revenue projected to reach 46.13 million USD, implying an increase of 0.00% EPS, and increase of 1.74% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
FAQ
What were Brainsway Ltd. - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Brainsway Ltd. - ADR reported EPS of $0.13, beating estimates by 35.63%, and revenue of $45.34M, -1.07% below expectations.
How did the market react to Brainsway Ltd. - ADR's Q3 2025 earnings?
The stock price moved down -5.83%, changed from $16.12 before the earnings release to $15.18 the day after.
When is Brainsway Ltd. - ADR expected to report next?
The next earning report is scheduled for Mar 09, 2026.
What are the forecasts for Brainsway Ltd. - ADR's next earnings report?
Based on 3
analysts, Brainsway Ltd. - ADR is expected to report EPS of $0.13 and revenue of $46.13M for Q4 2025.